GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Synagistics 2562.HK · HKD

N/A · HKEX · 🇭🇰 Hong Kong

Compare

0.37

-5.13%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Synagistics

Its shares trade on HKEX under the ticker 2562.HK. It has been listed since 15 August 2022. In the fiscal year to 31 December 2025, it reported revenue of SGD 508.7m and a net loss of SGD 312.3m. At that date it held total assets of SGD 833.8m and shareholders' equity of SGD 458.0m.

HK Acquisition Corp. is a special purpose acquisition company. The company employs 0 full-time employees The company went IPO on 2022-08-15. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm focuses on its area of Greater China and managed the investments in a number of companies globally in the finance, technology, life science and healthcare industries.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
15 Aug 2022

Leadership

Pay as last reported

  • Mr. Shieh-Peen LeeExecutive Chairman of the Board, Managing Director, since 2024
  • Mr. Ho Yan TaiChief Executive Officer, Executive Director, since 2024
  • Mr. Tung Ching NgCompany Secretary
  • Mr. Tian Taum ChongNon-Executive Director, since 2024
  • Mr. Nan Chie PhuaNon-Executive Director, since 2024
  • Mr. Andrew ZhengNon-Executive Director
  • Mr. Heng Cheong ChowNon-Executive Independent Director, since 2024
  • Mr. Selva RatnamNon-Executive Independent Director, since 2024
  • Mr. Wei Ting SiekNon-Executive Independent Director, since 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • HK Acquisition Corp. focuses on Greater China with global investments in finance and technology sectors.
  • The company has a clear IPO date of 15 August 2022 for business combinations.
  • HK Acquisition Corp. manages investments in life science and healthcare industries globally.

Weaknesses

  • HK Acquisition Corp. employs zero full-time employees as of the latest data.
  • The company has no employees to manage operations or investments directly.
  • HK Acquisition Corp. lacks a dedicated workforce for strategic business development.

Opportunities

  • Greater China market offers significant growth potential for business combinations.
  • Global investments in finance and technology sectors present expansion opportunities.
  • Life science and healthcare industries show strong potential for investment returns.

Threats

  • The lack of full-time employees may hinder timely business decisions.
  • No dedicated workforce could lead to operational inefficiencies in mergers.
  • Zero employees might limit the company's ability to respond to market changes.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.